Sanolium Group Holding AB reports third quarter 2019 result

Revenue in the third quarter amounted to 137.5 MSEK, corresponding to a growth of 19.8 percent 

Third quarter

- Revenue amounted to 137.5 (Q3-18 pro forma of 114.7) MSEK, corresponding to an increase of 19.8 percent.
- Ebitda amounted to 28.4 (Q3-18 pro forma of 28.3) MSEK
- Successful issuance of 500 MSEK Nordic Bond.
- Strategic acquisition of Daintel, a Danish software provider for intensive care.
- Divestment of UK operations to strategically streamline and focus the company’s operations

February 20 to September

- Revenue amounted to 334,4 (pro forma 286.6) MSEK, corresponding to an increase of 16.7 percent.
- EBITDA amounted to 57.2 (pro forma 69.0) MSEK. The decrease is driven by investments in operating expenses in order to deliver on the new Sussa contract, meet other commitments and to secure future growth.
- In June, Cambio signed a sizeable contract with a new customer group, Sussa, securing the delivery of its EHR system to 5 (up to 9) additional regions in Sweden, with a total contract value of 1.7 BSEK (up to 2.3 BSEK)

"The increased demand for our solutions traces back to the need for increased digitalization that we see in healthcare and social care. The regions and municipalities in Sweden need to invest much more in IT than what they have done historically. Cambio has the products and services to meet the technical gap that the regions and municipalities have to enable tomorrows healthcare and social care. Together with our costumers we contribute to a better and healthier society" 

- Peter Gille, CEO

For further information, please contact;

Peter Gille, CEO, Cambio Healthcare Systems
peter.gille@cambio.se
+46 70 825 00 14

Fredrik Rüdén, CFO, Cambio Healthcare Systems
fredrik.ruden@cambio.se
+46 76 001 84 22